Literature DB >> 32021804

ATAD3A variants manifest multisystematically in the brain, nerves, eyes, heart, liver, and skin.

Josef Finsterer1, Rahim Aliyev2.   

Abstract

Entities:  

Keywords:  ATAD3A; Cardiac involvement; Mitochondrial disorder; Multisystem; Phenotype; Pontocerebellar hypoplasia

Year:  2020        PMID: 32021804      PMCID: PMC6994402          DOI: 10.1016/j.ymgmr.2020.100569

Source DB:  PubMed          Journal:  Mol Genet Metab Rep        ISSN: 2214-4269


× No keyword cloud information.
In a recent article, Peralta et al. reported about 4 siblings from consanguineous parents with neonatal cerebellar hypoplasia, seizures, axial hypotonia, hypertrophic cardiomyopathy, hepatomegaly, congenital cataract, and facial dysmorphism due to the novel, homozygous missense variant c.1217T>G (p.Leu406Arg) in ATAD3A [1]. The study evokes the following concerns. We do not agree with the notion that hypertrophic cardiomyopathy and hepatomegaly “expand the phenotypic spectrum commonly associated with pathogenic ATAD3A variants” [1]. At least hypertrophic cardiomyopathy has been reported previously in 2 of 8 unrelated individuals carrying the variant c.1582C>T in ATAD3A [2]. One of the 8 individuals also presented with right ventricular hypertrophy. Hypertrophic cardiomyopathy has been also reported in one of 6 patients carrying deletions of the ATAD3A and ATAD3B gene respectively [3]. The only phenotypic features which have not been reported previously are hepatomegaly and low plasma cholesterol [1], The presence of hepatomegaly in all four siblings is not surprising given the fact that all four had cardiomyopathy. Assuming that all four had heart failure from cardiomyopathy, enlargement of the liver due to congestion is not unusual. We thus should know if the four siblings presented with other clinical features of heart failure (edema, neck vein distension), if systolic function was reduced, and if proBNP values were increased. In case hepatomegaly was not attributable to heart failure, we should know if there was steatosis or accumulation of other material on autopsy, or liver toxicity from drugs. Features which have been previously reported but not in the present study include fetal distress [2,3], feeding difficulties [2], optic atrophy [2], peripheral spasticity [2,4], and axonal neuropathy [2,4]. We should know what is meant with “peripheral spasticity” and if these features were truly absent or if the authors not systematically looked for them, This interesting study may profit from addressing the points mentioned above.

Funding

No funding was received.

Author contribution

JF: design, literature search, discussion, first draft, critical comments.

Declaration of Competing Interest

There are no conflicts of interest.
  4 in total

1.  Recurrent De Novo and Biallelic Variation of ATAD3A, Encoding a Mitochondrial Membrane Protein, Results in Distinct Neurological Syndromes.

Authors:  Tamar Harel; Wan Hee Yoon; Caterina Garone; Shen Gu; Zeynep Coban-Akdemir; Mohammad K Eldomery; Jennifer E Posey; Shalini N Jhangiani; Jill A Rosenfeld; Megan T Cho; Stephanie Fox; Marjorie Withers; Stephanie M Brooks; Theodore Chiang; Lita Duraine; Serkan Erdin; Bo Yuan; Yunru Shao; Elie Moussallem; Costanza Lamperti; Maria A Donati; Joshua D Smith; Heather M McLaughlin; Christine M Eng; Magdalena Walkiewicz; Fan Xia; Tommaso Pippucci; Pamela Magini; Marco Seri; Massimo Zeviani; Michio Hirano; Jill V Hunter; Myriam Srour; Stefano Zanigni; Richard Alan Lewis; Donna M Muzny; Timothy E Lotze; Eric Boerwinkle; Richard A Gibbs; Scott E Hickey; Brett H Graham; Yaping Yang; Daniela Buhas; Donna M Martin; Lorraine Potocki; Claudio Graziano; Hugo J Bellen; James R Lupski
Journal:  Am J Hum Genet       Date:  2016-09-15       Impact factor: 11.025

2.  Novel ATAD3A recessive mutation associated to fatal cerebellar hypoplasia with multiorgan involvement and mitochondrial structural abnormalities.

Authors:  Susana Peralta; Adrián González-Quintana; Marta Ybarra; Aitor Delmiro; Rafael Pérez-Pérez; Jorge Docampo; Joaquín Arenas; Alberto Blázquez; Cristina Ugalde; Miguel A Martín
Journal:  Mol Genet Metab       Date:  2019-11-06       Impact factor: 4.797

3.  ATAD3 gene cluster deletions cause cerebellar dysfunction associated with altered mitochondrial DNA and cholesterol metabolism.

Authors:  Radha Desai; Ann E Frazier; Romina Durigon; Harshil Patel; Aleck W Jones; Ilaria Dalla Rosa; Nicole J Lake; Alison G Compton; Hayley S Mountford; Elena J Tucker; Alice L R Mitchell; Deborah Jackson; Abdul Sesay; Miriam Di Re; Lambert P van den Heuvel; Derek Burke; David Francis; Sebastian Lunke; George McGillivray; Simone Mandelstam; Fanny Mochel; Boris Keren; Claude Jardel; Anne M Turner; P Ian Andrews; Jan Smeitink; Johannes N Spelbrink; Simon J Heales; Masakazu Kohda; Akira Ohtake; Kei Murayama; Yasushi Okazaki; Anne Lombès; Ian J Holt; David R Thorburn; Antonella Spinazzola
Journal:  Brain       Date:  2017-06-01       Impact factor: 13.501

4.  ATPase-deficient mitochondrial inner membrane protein ATAD3A disturbs mitochondrial dynamics in dominant hereditary spastic paraplegia.

Authors:  Helen M Cooper; Yang Yang; Emil Ylikallio; Rafil Khairullin; Rosa Woldegebriel; Kai-Lan Lin; Liliya Euro; Eino Palin; Alexander Wolf; Ras Trokovic; Pirjo Isohanni; Seppo Kaakkola; Mari Auranen; Tuula Lönnqvist; Sjoerd Wanrooij; Henna Tyynismaa
Journal:  Hum Mol Genet       Date:  2017-04-15       Impact factor: 6.150

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.